腹腔镜脾切除联合贲门周围血管离断术的临床疗效

Clinical efficacy of laparoscopic splenectomy combined with pericardial devascularization

  • 摘要: 目的:探讨腹腔镜脾切除联合贲门周围血管离断术的临床疗效。
    方法:采用回顾性横断面描述性研究方法。收集2012年4月至2015年6月昆明医科大学第二附属医院收治的64例行腹腔镜脾切除联合贲门周围血管离断术患者的临床资料。观察指标:(1)治疗结果:手术方式、手术时间、术中出血量(不包括脾脏内自体血)、术后胃肠功能恢复时间、术后腹腔引流管拔出时间、术后住院时间、并发症发生情况。(2)随访情况。术后采用门诊复查方式进行随访,术后1、2、3、6、12、24个月定期进行随访,随访时复查血常规、肝功能、凝血功能、胃镜及门静脉彩色多普勒超声。随访时间截至再次出现消化道出血,最终截止时间为患者死亡或接受肝移植。正态分布的计量资料采用±s表示。
    结果:(1)治疗结果:64例患者中,62例成功完成完全腹腔镜脾切除联合贲门周围血管离断术;1例术中出现不可控出血中转为手助腹腔镜脾切除联合贲门周围血管离断术;1例先行胆囊切除术,术中出血量约1 500 mL,术中输注悬浮RBC 6 U,血浆900 mL后,中止手术,1周后再行腹腔镜脾切除联合贲门周围血管离断术。围术期无术后出血、胰液漏并发症,无患者死亡。64例患者手术时间为(146±33)min,术中出血量为(214±31)mL,术后胃肠功能恢复时间为(24±4)h,术后第7天拔出引流管。术后住院时间为(14±6)d。9例患者术后出现左侧胸腔积液,行胸腔穿刺引流后好转。(2)随访情况:64例患者均获得门诊随访,随访时间为3.0~23.0个月,平均随访时间为19.7个月。所有患者术后第2个月复查电子胃镜显示食管下段及胃底曲张静脉情况明显好转或消失。术后3个月内4例患者发生门静脉血栓形成,PLT升高>700×109/L,栓溶二聚体>5则给予低分子肝素0.4 U皮下注射,直至栓溶二聚体<2。术后6个月3例患者失访,未发生上消化道出血、肝性脑病、肝衰竭等并发症。
    结论:腹腔镜脾切除联合贲门周围血管离断术是治疗门静脉高压症的一种安全有效的方法,严密的围术期处理可以为手术安全提供保障。

     

    Abstract: Objective:To investigate the clinical efficacy of laparoscopic splenectomy combined with pericardial devascularization.
    Methods:The retrospective cross-sectional descriptive study was adopted. The clinical data of 64 patients who underwent laparoscopic splenectomy combined with pericardial devascularization at the Second Affiliated Hospital of Kunming Medical University from April 2012 to June 2015 were collected. Observed indexes included (1) treatment outcomes, including surgical procedures, operation time, volume of intraoperative blood loss, time of postoperative enteral recovery, time of postoperative drainage tube removal, duration of postoperative hospital stay, occurrence of complications, (2)followup situation. The followup using reexaminations of blood routine, liver function, coagulation function, gastroscopy and color Doppler ultrasonography of portal vein was performed regularly at postoperative month 1, 2, 3, 6, 12, 24 until reemergence of gastrointestinal hemorrhage. The final deadline was death of patients and performance of liver transplantation. Measurement data with normal distribution were presented as ±s.
    Results:(1) Treatment outcomes: of 64 patients, 62 underwent total laparoscopic splenectomy combined with pericardial devascularization successfully. One patient was transffered to handassisted laparoscopic splenectomy combined with pericardial devascularization due to uncontrollable hemorrhage. One patient received laparoscopic cholecystectomy firstly with volume of blood loss of about 1 500 mL and terminated surgery after infusion of suspension red blood cells of 6 U and plasma of 900 mL, and underwent laparoscopic splenectomy combined with pericardial devascularization again next week. No postoperative hemorrhage, pancreatic leakage or death occurred during the perioperative period. The operation time,volume of intraoperative blood loss, time of postoperative enteral recovery, time of postoperative drainage tube removal and duration of postoperative hospital stay were (146±33)minutes, (214±31)mL, (24±4)hours, 7 days and (14±6)days, respectively. Nine patients had postoperative pleural effusion and recovered after thoracic drainage and thoracentesis. (2) Followup situation: All the 64 patients were followed up for an average time of 19.7 months (range, 3.0-23.0 months). Reexamination of gastroscopy showed improvement of varicosed veins of lower esophagus and fundus of stomach. During the postoperative 3 months, 4 patients had portal vein thrombosis with level of PLT>700×109/L. For patients with DDimer>5, low molecular weight heparin of 0.4 U was injected subcutaneously until DDimer<2. Three patients were loss to followup at postoperative month 6 without upper gastrointestinal hemorrhage, hepatic encephalopathy or liver failure.
    Conclusion:Laparoscopic splenectomy combined with pericardial devascularization is safe and effective for portal hypertension, and rigorous perioperative management offers guarantee for surgical safety.

     

/

返回文章
返回